ß2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. (2021)

First Author: Rao S
Attributed to:  ADIPOSE TISSUE DYSFUNCTION AND LIPOTOXICITY funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abk2267

PubMed Identifier: 34910547

Publication URI: http://europepmc.org/abstract/MED/34910547

Type: Journal Article/Review

Volume: 13

Parent Publication: Science translational medicine

Issue: 624

ISSN: 1946-6234